Key Drivers
- Stable Profitability
- Cash Flow Slippage
- Leverage Pressure
AIAI Summary
HSIC has shifted from a stable distributor story to a turnaround/execution trade: improving margins and raised guidance are encouraging, but the investment case now hinges on proving that earnings can convert into durable free cash flow before leverage and weak Q1 cash generation erode confidence.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Stable Profitability
- •Cash Flow Slippage
- •Leverage Pressure
HSIC remains fundamentally profitable with stable margins and adequate interest coverage, but weaker Q1 cash flow, meaningful leverage, and a not-cheap valuation temper the outlook.
Price Behavior
Key Price Behavior Insights:
- •Holding support
- •Lower highs
- •Weak rebound
HSIC remains in a short-term downtrend, with a tentative bounce holding above $69 support, but upside is capped unless it reclaims $74–$75.
Sharp drop to $68.99 on 2026-05-11 suggests a brief oversold bounce
Sentiment & News
Key News Insights:
- •Strong Q1 Results
- •AI Workflow Expansion
- •Steady Investor Outreach
Henry Schein delivered a strong Q1 earnings beat with higher margins and raised confidence in its core dental business, while expanding AI-enabled workflow tools and maintaining active investor engagement.
The news is modestly positive for HSIC, reinforcing operating momentum and longer-term growth potential through dental technology investment
Similar Companies in Healthcare
Other companies in the same sector with AI ratings